These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9885303)

  • 21. Biopharmaceutical characterization of oral controlled/modified-release drug products. In vitro/in vivo correlation of roxatidine.
    Frick A; Möller H; Wirbitzki E
    Eur J Pharm Biopharm; 1998 Nov; 46(3):313-9. PubMed ID: 9885304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison study of two glimepiride formulations bioavailability in healthy volunteers of both sexes after a single dose administration].
    Borges NC; Taveira Ydel A; Mazucheli JA; Haddad AL; Astigarraga RE; Moreno RA
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):950-5. PubMed ID: 17934662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New in-situ gelling biopolymer-based matrix for bioavailability enhancement of glimepiride; in-vitro/in-vivo x-ray imaging and pharmacodynamic evaluations.
    Awadeen RH; Boughdady MF; Meshali MM
    Pharm Dev Technol; 2019 Jun; 24(5):539-549. PubMed ID: 30259768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
    Zur M; Cohen N; Agbaria R; Dahan A
    Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Overencapsulation on the Disintegration and Dissolution of Licensed Formulations for Blinding in Randomized Controlled Trials.
    Maher S; Walsh SJ; Takyi J; Wakai A; Brayden DJ; Hayden JC
    J Pharm Sci; 2019 Mar; 108(3):1227-1235. PubMed ID: 30385287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saliva-resistant coating of tablets prevents oral release of penicillin: plasma but not saliva equivalence.
    Quiding H; Arwidsson HG; Grahn Håkansson E; Grahnén A; Holm S
    Eur J Clin Pharmacol; 1998; 54(9-10):749-52. PubMed ID: 9923579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
    Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
    Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
    Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic modeling of glimepiride plasma concentration in healthy subjects.
    Antonesi IM; Potur R; Potur DM; Ghiciuc CM; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):949-53. PubMed ID: 22046814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro--in silico--in vivo approach in biopharmaceutical drug characterization: metformin hydrochloride IR tablets.
    Beloica S; Cvijić S; Homšek I; Bogataj M; Parojčić J
    Pharmazie; 2015 Jul; 70(7):458-65. PubMed ID: 26373206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose linearity assessment of glimepiride (Amaryl) tablets in healthy volunteers.
    Malerczyk V; Badian M; Korn A; Lehr KH; Waldhäusl W
    Drug Metabol Drug Interact; 1994; 11(4):341-57. PubMed ID: 12369757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute bioavailability of glimepiride (Amaryl) after oral administration.
    Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
    Drug Metabol Drug Interact; 1994; 11(4):331-9. PubMed ID: 12369756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
    Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
    Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic Acid.
    Hofsäss MA; Souza J; Silva-Barcellos NM; Bellavinha KR; Abrahamsson B; Cristofoletti R; Groot DW; Parr A; Langguth P; Polli JE; Shah VP; Tajiri T; Mehta MU; Dressman JB
    J Pharm Sci; 2017 Dec; 106(12):3421-3430. PubMed ID: 28842299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits.
    Shirtliff ME; Calhoun JH; Mader JT
    J Antimicrob Chemother; 2001 Aug; 48(2):253-8. PubMed ID: 11481297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of glimepiride polymorphs.
    Viana ALM; Doriguetto AC; Viana OMMS; Ruela ALM; Freitas JTJ; Souto BEM; de Araújo MB; de Araújo Paula FB
    Int J Pharm; 2018 Dec; 553(1-2):272-280. PubMed ID: 30359686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.